|
Volumn 54, Issue 1, 2006, Pages 147-148
|
New strategies in melanoma
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE;
EFLORNITHINE;
EPIGALLOCATECHIN GALLATE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMIQUIMOD;
MELANOCORTIN 1 RECEPTOR;
MEVINOLIN;
ORNITHINE DECARBOXYLASE INHIBITOR;
PERILLYL ALCOHOL;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
RAS PROTEIN;
RETINOID;
SILYMARIN;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CANCER PREVENTION;
CANCER RISK;
CARCINOGENESIS;
CELL CYCLE REGULATION;
CELL PROLIFERATION;
CORONARY ARTERY DISEASE;
DNA DAMAGE;
DNA SYNTHESIS;
GENE MUTATION;
GENETIC POLYMORPHISM;
GENETIC SUSCEPTIBILITY;
HIGH RISK POPULATION;
HUMAN;
IMMUNE DEFICIENCY;
MELANOMA;
NONHUMAN;
NOTE;
PATIENT EDUCATION;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
SKIN CANCER;
|
EID: 29244482557
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaad.2005.09.006 Document Type: Article |
Times cited : (1)
|
References (11)
|